Key points are not available for this paper at this time.
Accelerated TMS demonstrated an excellent safety profile with efficacy comparable to that achieved in daily rTMS in other trials. Limitations primarily include open-label treatment and a small sample size.
Holtzheimer et al. (Mon,) studied this question.